浙江:到2025年中藥工業企業主營業務收入突破400億人幣
浙江省發改委、經信廳、農業農村廳、衛健委、中醫藥管理局發佈關於《浙江省中醫藥發展「十四五」規劃》通知指出,到2025年,中醫藥強省建設取得明顯進展,整合型中醫藥服務體系基本成熟定型,中醫藥創新發展能力和融合發展水平大幅提升,中醫藥產業競爭力明顯增強,中醫藥對提高居民健康水平的貢獻度進一步凸顯。
在中醫服務能力提升方面,建成一批國家、省級中醫醫學中心和區域醫療中心,各設區市至少設置一所三級甲等水平的中醫醫院,95%的縣級中醫醫院達到二級甲等以上水平,公立中醫醫院中醫類執業(助理)醫師佔比達60%以上,中醫藥特色服務人次佔中醫醫院總診療人次比率達65%以上,公立中醫醫院在全國績效考覈中總體排名進入全國前十等。
在擴大中藥產業規模方面,中藥材種植總面積達100萬畝,中藥工業企業主營業務收入突破400億元人民幣,形成若幹規模化中醫藥產業集羣,壯大一批龍頭企業,培育一批「浙產中藥」知名品牌,努力打造中醫藥產業高質量發展集聚地。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.